ARCHIVES

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

This article is from The Cancer Letter archive.

Vol. 29 No. 15 | April 11, 2003

Download PDF Visit The Full Archive

Related Articles

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

CVS To Stop Tobacco Sales at Pharmacies

February 7, 2014

In Brief: CDP Services Wins ASC Planning Contract; Jury Finds Sarin Guilty of Embezzlement

July 17, 1992

Letter: Cancer Centers Need Ingenuity To Continue Clinical Research

October 27, 1995

NCI Proposes Consolidation of Nine Cooperative Groups to Four

December 17, 2010